ENPICOM

ENPICOM is a commercial life-science software company headquartered in 's-Hertogenbosch, Netherlands. It operates at the intersection of bioinformatics, immunology, and software engineering, building tools that help researchers and biopharmaceutical organizations make sense of high-throughput immune repertoire sequencing (Rep-Seq) data. The company is best known for its ImmunoGenetics platform, a suite of software products designed to process, analyze, visualize, and manage T-cell and B-cell receptor repertoire data generated by next-generation sequencing. ENPICOM's offerings are aimed at immunology research, immuno-oncology, antibody discovery, vaccine development, and related areas of translational and clinical research. Its platform is intended to support the full data lifecycle — from raw sequencing reads through clonotype assignment, diversity and repertoire metrics, and downstream interpretation — while also providing data management and collaboration features for research teams. By packaging complex bioinformatics pipelines into user-friendly software, ENPICOM positions itself as a bridge between sequencing service providers, academic immunology groups, and drug developers who need reproducible, scalable repertoire analysis. The company is a private entity based in the Netherlands and serves customers internationally, with a focus on European and global life-science markets. Its brand identity is tied to the growing field of immunoinformatics, where software and data science are increasingly central to immunology research and therapeutic development. ENPICOM's public presence centers on its website, product documentation, scientific collaborations, and participation in the immunology and bioinformatics communities. Because ENPICOM is a specialized B2B software vendor rather than a consumer brand, its visibility is concentrated among researchers, core sequencing facilities, and biotech/pharma R&D teams. Its commercial proposition rests on domain expertise in immune repertoire analysis, the usability and scalability of its software, and its ability to keep pace with evolving sequencing technologies and immunology research methods.

ENPICOM is a Netherlands-based life-science software company located in 's-Hertogenbosch. It was founded to address the growing need for accessible, scalable software in the field of immunoinformatics, particularly for the analysis of immune repertoire sequencing data. The company developed its ImmunoGenetics platform to help researchers and biopharmaceutical organizations process and interpret T-cell and B-cell receptor repertoire data generated by next-generation sequencing. As immune repertoire sequencing became more widely adopted in immunology, immuno-oncology, antibody discovery, and vaccine research, ENPICOM positioned its software as a bridge between sequencing data generation and biological insight. The platform is designed to support the full analysis workflow, from raw sequencing reads through clonotype assignment, repertoire metrics, visualization, and data management, with an emphasis on usability for research teams that may not have extensive bioinformatics resources. ENPICOM operates as a private company based in the Netherlands and serves customers internationally, with a focus on European and global life-science markets. Its brand is associated with the specialized field of immunoinformatics, and its public presence centers on its website, product documentation, scientific collaborations, and engagement with the immunology and bioinformatics communities. Detailed public information about its founding date, founders, funding, and corporate ownership is limited in the available evidence.

Specialist B2B software provider for immune repertoire sequencing analysis and immunoinformatics, serving immunology research and biopharma R&D.

• ImmunoGenetics platform

  Software platform for processing, analyzing, visualizing, and managing immune repertoire sequencing data.

• 2022.01.14

  Reported2022.01.14

  ENPICOM closes Series B funding round[3]ENPICOM完成B轮融资openpr.com

  ENPICOM announced that it had closed a capital investment round led by BOP Capital to support growth and scale its operations.

Read more

1. 1ENPICOM (Netherlands) — Wikidatawikidata.org
2. 2ENPICOM official websiteenpicom.com
3. 3ENPICOM完成B轮融资openpr.com